The estimated Net Worth of Phillip Barnes is at least $17.3 Mille dollars as of 5 September 2023. Phillip Barnes owns over 5,000 units of VolitionRX Ltd stock worth over $17,256 and over the last 5 years he sold VNRX stock worth over $0. In addition, he makes $0 as Independent Director at VolitionRX Ltd.
Phillip has made over 1 trades of the VolitionRX Ltd stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of VNRX stock worth $6,500 on 5 September 2023.
The largest trade he's ever made was buying 5,000 units of VolitionRX Ltd stock on 5 September 2023 worth over $6,500. On average, Phillip trades about 417 units every 0 days since 2020. As of 5 September 2023 he still owns at least 24,686 units of VolitionRX Ltd stock.
You can see the complete history of Phillip Barnes stock trades at the bottom of the page.
Dr. Phillip Barnes serves as Independent Director of the Company. Dr. Barnes holds a BSc and PhD from the University of London and a clinical medical degree (BM BCh) from the University of Oxford. Dr. Barnes is currently retired. Between 2009 and his retirement in 2016, Dr. Barnes served as Executive Medical Director on a number of United Kingdom Department of Health, National Health Service (“NHS”) hospital and Foundation Trust Boards. Between 2000 and 2009, Dr. Barnes was also involved in a number of national and regional advisory groups for the NHS and pharmaceutical industry. Dr. Barnes was Consultant Neurologist at King’s College Hospital, London, from 1995 to 2009 and Hon. Senior Lecturer in Neurology at King’s College London from 1999 to 2009. From 1995 to 1998, Dr. Barnes served as Clinical Director for Neurology and from 1998 until 2008 as Director of the King’s Neurosciences Centre, the United Kingdom’s largest Regional Neuroscience Centre. Our board of directors believes that Dr. Barnes is qualified to serve as a director of the Company based on his extensive experience both as a clinician and clinical manager within the United Kingdom’s NHS and related academic institutions.
Phillip Barnes is 58, he's been the Independent Director of VolitionRX Ltd since 2019. There are 8 older and 13 younger executives at VolitionRX Ltd. The oldest executive at VolitionRX Ltd is Dr. Martin Charles Faulkes Ph.D., 77, who is the Exec. Chairman.
Phillip's mailing address filed with the SEC is 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014.
Over the last 12 years, insiders at VolitionRX Ltd have traded over $775,239 worth of VolitionRX Ltd stock and bought 1,908,474 units worth $44,487,770,972 . The most active insiders traders include Guy Archibald Innes, Cameron John Reynolds e Martin Charles Faulkes. On average, VolitionRX Ltd executives and independent directors trade stock every 43 days with the average trade being worth of $27,899. The most recent stock trade was executed by Guy Archibald Innes on 20 August 2024, trading 150,000 units of VNRX stock currently worth $100,500.
volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.
VolitionRX Ltd executives and other stock owners filed with the SEC include: